Efficacy of Hypnosis and Catalepsy Induction in Functional Neurological Disorders.
behavioral therapy
catalepsy-induction
functional neurological disorder
hypnosis
Journal
Movement disorders clinical practice
ISSN: 2330-1619
Titre abrégé: Mov Disord Clin Pract
Pays: United States
ID NLM: 101630279
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
revised:
26
10
2023
received:
24
04
2023
accepted:
04
11
2023
medline:
22
2
2024
pubmed:
22
2
2024
entrez:
22
2
2024
Statut:
ppublish
Résumé
Patients with Functional Neurological Disorder (FND) experience complex patterns of motor and/or sensory symptoms. Treatment studies of psychological interventions are promising but limited. The aim of the current pilot study is to investigate the effect of treatment consisting of a combination of hypnosis and catalepsy induction on FND symptom severity. A within-subject waiting list-control design was used with 46 patients diagnosed with FND. The treatment consisted of 10 sessions. The primary outcome measure was FND symptom severity (The Psychogenic Movement Disorder Rating Scale; PMDRS). The secondary outcome measures were psychological distress and quality of life. The repeated measures (RM) ANOVA for the PMDRS as outcome measure revealed a significant effect for time with a large effect size (η This pilot study showed that eight sessions of treatment consisting of a combination of hypnosis and catalepsy induction was effective in reducing FND symptom severity. Some explanations and limitations are provided in the paper as well as several avenues of future research.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with Functional Neurological Disorder (FND) experience complex patterns of motor and/or sensory symptoms. Treatment studies of psychological interventions are promising but limited.
OBJECTIVES
OBJECTIVE
The aim of the current pilot study is to investigate the effect of treatment consisting of a combination of hypnosis and catalepsy induction on FND symptom severity.
METHODS
METHODS
A within-subject waiting list-control design was used with 46 patients diagnosed with FND. The treatment consisted of 10 sessions. The primary outcome measure was FND symptom severity (The Psychogenic Movement Disorder Rating Scale; PMDRS). The secondary outcome measures were psychological distress and quality of life.
RESULTS
RESULTS
The repeated measures (RM) ANOVA for the PMDRS as outcome measure revealed a significant effect for time with a large effect size (η
CONCLUSIONS
CONCLUSIONS
This pilot study showed that eight sessions of treatment consisting of a combination of hypnosis and catalepsy induction was effective in reducing FND symptom severity. Some explanations and limitations are provided in the paper as well as several avenues of future research.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
129-135Informations de copyright
© 2023 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Références
Diagnostic and statistical manual of mental disorders: DSM-5™. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol 2018;75(9):1132-1141.
Stone J, Carson A, Duncan R, et al. Symptoms ‘unexplained by organic disease’ in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain 2009;132(Pt 10):2878-2888.
Feinstein A. Conversion disorder. Continuum 2018;24(3):861-872.
Miyasaki JM, Sa DS, Galvez-Jimenez N, Lang AE. Psychogenic movement disorders. Can J Neurol Sci 2003;30(suppl 1):S94-S100.
Fobian AD, Elliott L. A review of functional neurological symptom disorder etiology and the integrated etiological summary model. J Psychiatry Neurosci 2019;44(1):8-18.
Ricciardi L, Edwards MJ. Treatment of functional (psychogenic) movement disorders. Neurotherapeutics 2014;11(1):201-207.
Nicholson TR, Carson A, Edwards MJ, et al. Outcome measures for functional neurological disorder: a review of the rheoretical complexities. J Neuropsychiatry Clin Neurosci 2020;32(1):33-42.
Edwards MJ, Adams RA, Brown H, Pareés I, Friston KJ. A Bayesian account of ‘hysteria’. Brain 2012;135(Pt 11):3495-3512.
Hoogduin CAL, De Kleine R, Van Minnen A, et al. Protocollaire behandeling van patiënten met een conversiestoornis (functioneel-neurologisch-symptoomstoornis). In: Keijsers G, Van Minnen A, Verbraak M, eds. Protocollaire behandelingen voor volwassenen met psychische klachten. Amsterdam: Boom; 2017:283-350.
Moene FC, Spinhoven P, Hoogduin KAL, van Dyck R. A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychother Psychosom 2002;71(2):66-76.
Moene FC, Spinhoven P, Hoogduin KAL, van Dyck R. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn 2003;51(1):29-50.
Deeley Q. Hypnosis as therapy for functional neurologic disorders. Handb Clin Neurol 2016;139:585-595.
Wieder L, Brown R, Thompson T, Terhune DB. Suggestibility in functional neurological disorder: a meta-analysis. J Neurol Neurosurg Psychiatry 2021;92(2):150-157.
Hagenaars MA, Roelofs K, Hoogduin K, Van Minnen A. Motor and sensory dissociative phenomena associated with induced catalepsy: a brief communication. Int J Clin Exp Hypn 2006;54(2):234-244.
Tibben MI, Hoogduin CAL. In: Spaans J, Rosmalen Y, Van Rood H, eds. Handboek behandeling van somatisch onvoldoende verklaarde lichamelijke klachten. Houten: Uitgeverij LannooCampus; 2017:351-364.
Hinson VK, Cubo E, Comella CL, Goetz CG, Leurgans S. Rating scale for psychogenic movement disorders: scale development and clinimetric testing. Mov Disord 2005;20(12):1592-1597.
Nienhuis FJ, van de Willige G, Rijnders CAT, de Jonge P, Wiersma D. Validity of a short clinical interview for psychiatric diagnosis: the mini-SCAN. Br J Psychiatry 2010;196(1):64-68.
Pick S, Anderson DG, Asadi-Pooya AA, et al. Outcome measurement in functional neurological disorder: a systematic review and recommendations. J Neurol Neurosurg Psychiatry 2020;91(6):638-649.
Carlier I, Schulte-Van Maaren Y, Wardenaar K, et al. Development and validation of the 48-item symptom questionnaire (SQ-48) in patients with depressive, anxiety and somatoform disorders. Psychiatry Res 2012;200(2-3):904-910.
The World Health Organization quality of life assessment (WHOQoL): development and general psychometric properties. Soc Sci Med 1998;46(12):1569-1585.
Carlier IVE, Kovács V, van Noorden MS, et al. Evaluating the responsiveness to therapeutic change with routine outcome monitoring: a comparison of the symptom Questionnaire-48 (SQ-48) with the brief symptom inventory (BSI) and the outcome Questionnaire-45 (OQ-45). Clin Psychol Psychother 2017;24(1):61-71.
Trompenaars FJ, Masthoff ED, Van Heck GL, Hodiamont PP, De Vries J. Content validity, construct validity, and reliability of the WHOQoL-Bref in a population of Dutch adult psychiatric outpatients. Qual Life Res 2005;14(1):151-160.
Chow DL, Miller SD, Seidel JA, Kane RT, Thornton JA, Andrews WP. The role of deliberate practice in the development of highly effective psychotherapists. Psychotherapy (Chic) 2015;52(3):337-345.
Miller WR, Moyers TB. Effective Psychotherapists: Clinical Skills that Improve Client Outcomes. New York: The Guilford Press; 2021.
Sacerdote P. An analysis of induction procedures in hypnosis. Am J Clin Hypn 1970;12(4):236-253.
Hoogduin CAL. Psychologische interventies bij conversiestoornissen. Amsterdam: Boom; 2007.
Gelauff JM, Kingma EM, Kalkman JS, et al. Fatigue, not self-rated motor symptom severity, affects quality of life in functional motor disorders. J Neurol 2018;265(8):1803-1809.
Carson AJ, Brown R, David AS, et al. Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry 2012;83(8):842-850.